TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures per share in JPY.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 333.19 | 350.51 | 334.99 | 380.10 | 365.22 | 360.92 | 333.02 | 348.41 | 352.72 | 378.54 | 356.69 | 380.10 | 1,452.14 | |
| 109.75 | 119.70 | 123.47 | 121.76 | 122.45 | 131.51 | 120.79 | 121.11 | 120.47 | 172.50 | 182.67 | 126.71 | 595.26 | |
| 223.44 | 230.80 | 211.52 | 258.34 | 242.77 | 229.42 | 212.22 | 227.31 | 232.25 | 206.04 | 174.02 | 253.38 | 856.88 | |
| 58.76 | 59.11 | 62.43 | 53.01 | 54.52 | 53.69 | 68.28 | 45.30 | 51.18 | 55.66 | 63.65 | 52.16 | 220.03 | |
| 80.80 | 84.38 | 90.93 | 84.97 | 83.32 | 85.36 | 93.53 | 80.56 | 80.37 | 88.23 | 93.44 | 89.27 | 347.36 | |
| 239.20 | 197.71 | 214.73 | 206.01 | 185.55 | 208.30 | 235.90 | 169.20 | 210.38 | 145.49 | 158.81 | 190.63 | 697.35 | |
| -15.76 | 33.09 | -3.21 | 52.34 | 57.22 | 21.12 | -23.68 | 58.11 | 21.87 | 60.55 | 15.21 | 62.76 | 159.53 | |
| 0.13 | 21.00 | 0.10 | 18.78 | 21.26 | 0.07 | 0.10 | 33.74 | 26.35 | 39.27 | 14.22 | 19.89 | 98.86 | |
| -30.66 | 19.32 | -15.15 | 42.98 | 37.07 | 8.33 | -33.92 | 47.42 | 8.93 | 42.52 | -17.10 | 50.70 | 85.29 | |
| -15.34 | -14.04 | -14.19 | 13.00 | 8.47 | 0.81 | -1.33 | 8.30 | 12.65 | 9.57 | -9.20 | 15.41 | 28.45 | |
| -15.34 | 33.35 | -0.96 | 29.97 | 28.59 | 7.50 | -32.63 | 39.11 | -3.74 | 32.92 | -7.93 | 35.27 | 56.75 | |
| 64.62 | 81.07 | 82.64 | 122.25 | 118.10 | 60.89 | 57.31 | 138.34 | 100.31 | 142.35 | 50.52 | 105.16 | 395.10 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.